XQ 1H
Alternative Names: XQ-1HLatest Information Update: 28 Oct 2024
Price :
$50 *
At a glance
- Originator Jiangsu Carephar Pharmaceutical
- Class Amines; Lactones; Small molecules; Sulfones; Vascular disorder therapies
- Mechanism of Action Platelet activating factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Stroke
Most Recent Events
- 28 Oct 2024 No recent reports of development identified for phase-I development in Stroke in China (Injection)
- 28 Oct 2024 No recent reports of development identified for phase-I development in Stroke in China (Tablet)
- 28 Sep 2021 Phase-I clinical trials in Stroke in China (unspecified route) (unspecified route, Injection) before September 2021 (Jiangsu Carephar Pharmaceuticals pipeline, September 2021)